Development and Validation of a Functional Antibody Assay for Evaluating Protein-Based Pneumococcal Vaccines

Key Points

• The study establishes a standardized framework for evaluating protein-based pneumococcal vaccines, enhancing regulatory processes.
• It provides a functional antibody assay that assesses the efficacy of various pneumococcal vaccine candidates effectively.
• Standardization improves consistency and accuracy in evaluating immune responses generated by protein-based vaccines.
• The findings suggest a potential improvement in vaccine development timelines and regulatory approval processes.

Abstract